Dashboard
Manage Tickers

LXRXLEXICON PHARMACEUTICALS, INC.

Nasdaq lexpharma.com


$ 1.67 $ 0.01 (0.6 %)    

Friday, 05-Jul-2024 15:59:56 EDT
CLICK TO SEE RELEVANT LITIGATION UPDATES
Y-mAbs Therapeutics, Inc. | YMAB | Take Action!
QQQ $ 495.80 $ 5.12 (1.04 %)
DIA $ 393.71 $ 0.87 (0.22 %)
SPY $ 554.29 $ 3.18 (0.58 %)
TLT $ 92.56 $ 0.76 (0.83 %)
GLD $ 220.89 $ 2.94 (1.35 %)
$ 1.67
$ 1.66
$ 1.65 x 200
$ 1.67 x 3,783
$ 1.62 - $ 1.67
$ 0.92 - $ 3.73
1,513,426
na
411.22M
$ 1.04
nm
TBD
na
na ($ 0.00)
na
TBD na
How to Read 10-K & 10-Q Reports To View SEC Filing Reports, Please Register or Sign In
# Filing Date Period End Date Type Report Link
1 05-02-2024 03-31-2024 10-Q
2 03-25-2024 12-31-2023 10-K
3 11-08-2023 09-30-2023 10-Q
4 08-04-2023 06-30-2023 10-Q
5 05-04-2023 03-31-2023 10-Q
6 03-03-2023 12-31-2022 10-K
7 11-09-2022 09-30-2022 10-Q
8 08-03-2022 06-30-2022 10-Q
9 05-05-2022 03-31-2022 10-Q
10 03-10-2022 12-31-2021 10-K
11 11-09-2021 09-30-2021 10-Q
12 08-06-2021 06-30-2021 10-Q
13 05-06-2021 03-31-2021 10-Q
14 03-12-2021 12-31-2020 10-K
15 10-30-2020 09-30-2020 10-Q
16 07-29-2020 06-30-2020 10-Q
17 04-27-2020 03-31-2020 10-Q
18 03-12-2020 12-31-2019 10-K
19 11-07-2019 09-30-2019 10-Q
20 08-01-2019 06-30-2019 10-Q
21 05-01-2019 03-31-2019 10-Q
22 03-15-2019 12-31-2018 10-K
23 11-01-2018 09-30-2018 10-Q
24 07-30-2018 06-30-2018 10-Q
25 05-03-2018 03-31-2018 10-Q
26 03-01-2018 12-31-2017 10-K
27 11-08-2017 09-30-2017 10-Q
28 08-01-2017 06-30-2017 10-Q
29 05-04-2017 03-31-2017 10-Q
30 03-06-2017 12-31-2016 10-K
31 11-07-2016 09-30-2016 10-Q
32 08-04-2016 06-30-2016 10-Q
33 05-05-2016 03-31-2016 10-Q
34 03-11-2016 12-31-2015 10-K
35 11-09-2015 09-30-2015 10-Q
36 08-07-2015 06-30-2015 10-Q
37 05-05-2015 03-31-2015 10-Q
38 03-12-2015 12-31-2014 10-K
39 11-06-2014 09-30-2014 10-Q
40 08-07-2014 06-30-2014 10-Q
Guide for Analyst Ratings To View Analyst Ratings, Please Register or Sign In
# Date Analyst Firm Upside/Downside Price Target Change Rating Change Current Rating

News

OPINIONS

hc-wainwright--co-reiterates-buy-on-lexicon-pharmaceuticals-maintains-10-price-target
HC Wainwright & Co. Reiterates Buy on Lexi...
06/24/2024 10:36:16

HC Wainwright & Co. analyst Joseph Pantginis reiterates Lexicon Pharmaceuticals (NASDAQ:LXRX) with a Buy and maintains $...

hc-wainwright--co-reiterates-buy-on-lexicon-pharmaceuticals-maintains-10-price-target
HC Wainwright & Co. Reiterates Buy on Lexi...
06/21/2024 14:15:03

HC Wainwright & Co. analyst Joseph Pantginis reiterates Lexicon Pharmaceuticals (NASDAQ:LXRX) with a Buy and maintains $...

lexicon-pharmaceuticals-resubmits-nda-for-sotagliflozin-as-adjunct-to-insulin-therapy-for-glycemic-control-in-type-1-diabetes-and-chronic-kidney-disease-expects-six-month-review-and-potential-early-2025-launch
Lexicon Pharmaceuticals Resubmits NDA For ...
06/21/2024 12:02:55

reported-wednesday-lexicon-published-data-from-relief-dpn-1-phase-2-study-of-lx9211-in-diabetes-care
Reported Wednesday, Lexicon Published Data...
06/20/2024 09:19:54

Clinical trial of LX9211, an investigational non-opioid investigational therapy, demonstrated clinically significant benefits...

lexicon-pharmaceuticals-presents-analysis-of-inpefa-cost-effectiveness-published-in-jacc-heart-failure-the-peer-reviewed-journal-of-the-american-college-of-cardiology
Lexicon Pharmaceuticals Presents Analysis ...
06/18/2024 12:20:03

New analysis of the pivotal Phase 3 SOLOIST-WHF trial demonstrates INPEFA cost-effectiveness Findings consistent with another s...

why-ovid-therapeutics-shares-are-trading-lower-by-19-here-are-other-stocks-moving-in-mondays-mid-day-session
Why Ovid Therapeutics Shares Are Trading L...
06/17/2024 17:21:47

aarons-mirum-pharmaceuticals-primo-water-and-other-big-stocks-moving-higher-on-monday
Aaron's, Mirum Pharmaceuticals, Primo Wate...
06/17/2024 13:59:35

hc-wainwright--co-initiates-coverage-on-lexicon-pharmaceuticals-with-buy-rating-announces-price-target-of-10
HC Wainwright & Co. Initiates Coverage On ...
06/17/2024 10:21:08

HC Wainwright & Co. analyst Joseph Pantginis initiates coverage on Lexicon Pharmaceuticals (NASDAQ:LXRX) with a Buy rati...

lexicon-pharmaceuticals-presents-findings-on-the-burdens-of-diabetic-peripheral-neuropathic-pain-among-3-sponsored-presentations-at-the-84th-scientific-sessions-of-the-american-diabetes-association
Lexicon Pharmaceuticals Presents Findings ...
06/14/2024 12:15:36

Lexicon Pharmaceuticals, Inc. (NASDAQ:LXRX) today announced that three poster presentations will be delivered during the 84th S...

needham-reiterates-hold-on-lexicon-pharmaceuticals
Needham Reiterates Hold on Lexicon Pharmac...
05/03/2024 12:25:01

Needham analyst Joseph Stringer reiterates Lexicon Pharmaceuticals (NASDAQ:LXRX) with a Hold.

lexicon-pharmaceuticals-q1-2024-gaap-eps-020-inline-sales-1130m-miss-1401m-estimate
Lexicon Pharmaceuticals Q1 2024 GAAP EPS $...
05/02/2024 20:07:55

Lexicon Pharmaceuticals (NASDAQ:LXRX) reported quarterly losses of $(0.20) per share which met the analyst consensus estimate. ...

leerink-partners-initiates-coverage-on-lexicon-pharmaceuticals-with-outperform-rating-announces-price-target-of-5
Leerink Partners Initiates Coverage On Lex...
04/30/2024 12:49:42

Leerink Partners initiates coverage on Lexicon Pharmaceuticals (NASDAQ:LXRX) with a Outperform rating and announces Price Tar...

lexicon-pharmaceuticals-ceo-lonnel-coats-retires
Lexicon Pharmaceuticals CEO Lonnel Coats R...
04/29/2024 13:05:08

needham-reiterates-hold-on-lexicon-pharmaceuticals
Needham Reiterates Hold on Lexicon Pharmac...
04/23/2024 09:48:35

Needham analyst Joseph Stringer reiterates Lexicon Pharmaceuticals (NASDAQ:LXRX) with a Hold.

matterport-sea-limited-ingevity-and-other-big-stocks-moving-higher-on-monday
Matterport, Sea Limited, Ingevity And Othe...
04/22/2024 14:10:39

needham-reiterates-hold-on-lexicon-pharmaceuticals
Needham Reiterates Hold on Lexicon Pharmac...
04/11/2024 10:20:36

Needham analyst Joseph Stringer reiterates Lexicon Pharmaceuticals (NASDAQ:LXRX) with a Hold.

why-luxurban-hotels-shares-are-trading-lower-by-around-27-here-are-other-stocks-moving-in-wednesdays-mid-day-session
Why LuxUrban Hotels Shares Are Trading Low...
03/27/2024 17:06:58

Shares of LuxUrban Hotels Inc. (NASDAQ: LUXH) fell sharply during Wednesday’s session after the company issued preliminary fo...

cintas-reports-upbeat-earnings-joins-paysign-noah-holdings-and-other-big-stocks-moving-higher-on-wednesday
Cintas Reports Upbeat Earnings, Joins PayS...
03/27/2024 14:03:27

U.S. stocks were higher, with the Dow Jones index gaining around 300 points on Wednesday.

lexicon-pharmaceuticals-announces-clinical-data-on-the-impact-of-sotagliflozin-on-stroke-and-heart-attack-risk-among-four-lexicon-sponsored-presentations-at-the-american-college-of-cardiology-73rd-annual-scientific-session--expo
Lexicon Pharmaceuticals Announces Clinical...
03/25/2024 13:25:31

Lexicon Pharmaceuticals, Inc. (NASDAQ:LXRX) today announced that four data presentations related to sotagliflozin, an inhibitor...

lexicon-pharmaceuticals-inc-announces-new-post-hoc-analysis-of-intandem3-study-demonstrates-improvements-in-glycemic-control-with-sotagliflozin-treatment-in-patients-with-type-1-diabetes-and-chronic-kidney-disease
Lexicon Pharmaceuticals, Inc. Announces Ne...
03/12/2024 12:06:57

Lexicon Pharmaceuticals, Inc. (NASDAQ:LXRX) today announced that a post hoc analysis of clinical data from its inTandem3 Phase ...

CORE & Plaid

CORE & Plaid

CORE Finalist

CLASS ACTION DEADLINES - JOIN NOW!

07/09/2024 Li Auto Inc. (LI)
07/12/2024 Inari Medical, Inc. (NARI)
07/12/2024 Sprout Social, Inc. (SPT)
07/15/2024 UnitedHealth Group Inc. (UNH)
07/16/2024 Teladoc Health, Inc. (TDOC)
07/16/2024 Vestis Corporation (VSTS)
07/22/2024 Cambium Networks Corporation (CMBM)
07/22/2024 Biogen Inc. (BIIB)
07/23/2024 Fastly, Inc. (FSLY)
07/29/2024 Enphase Energy, Inc. (ENPH)

NEW CASE INVESTIGATION

Ooma Inc (OOMA) AnaptysBio Inc (ANAB)